We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
-11.68%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$48.5B
AUM Growth
-$10.3B
Cap. Flow
-$1.41B
Cap. Flow %
-2.9%
Top 10 Hldgs %
41.47%
Holding
822
New
91
Increased
234
Reduced
365
Closed
101

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$1.11B
2
PG icon
Procter & Gamble
PG
+$595M
3
QCOM icon
Qualcomm
QCOM
+$385M
4
NVO
Novo Nordisk
NVO
+$317M
5
MAR icon
Marriott International
MAR
+$194M

Sector Composition

Rank Sector Weight
1 Technology 24.39%
2 Consumer Discretionary 17.07%
3 Healthcare 16.2%
4 Communication Services 11.46%
5 Financials 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARES icon
151
Ares Management
ARES
$30.7B
$20.3M 0.04%
656,983
-7,238
-1% -$253K
FAF icon
152
First American
FAF
$7.37B
$20.1M 0.04%
474,592
+199,952
+73% +$11.4M
CIEN icon
153
Ciena
CIEN
$56.2B
$20M 0.04%
502,752
+27,416
+6% +$1.12M
EYE icon
154
National Vision
EYE
$1.78B
$19.8M 0.04%
1,021,796
-94,797
-8% -$2.95M
UFPI icon
155
UFP Industries
UFPI
$5.01B
$19.7M 0.04%
528,818
+163,298
+45% +$7.5M
EPZM
156
DELISTED
Epizyme, Inc
EPZM
$19.6M 0.04%
1,266,544
-334,749
-21% -$7.19M
BIDU icon
157
Baidu
BIDU
$37.1B
$19.6M 0.04%
194,841
-3,685
-2% -$449K
WST icon
158
West Pharmaceutical
WST
$25.1B
$19.6M 0.04%
128,983
-1,423
-1% -$219K
PTCT icon
159
PTC Therapeutics
PTCT
$6.14B
$19.6M 0.04%
439,151
+2,666
+0.6% +$134K
NTRA icon
160
Natera
NTRA
$45.5B
$19.5M 0.04%
+651,481
New +$21.8M
RETA
161
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$19.3M 0.04%
133,889
+17,909
+15% +$3.46M
NUVA
162
DELISTED
NuVasive, Inc.
NUVA
$19.3M 0.04%
+380,356
New +$25.5M
POST icon
163
Post Holdings
POST
$3.5B
$19.2M 0.04%
353,255
-5,305
-1% -$345K
VST icon
164
Vistra
VST
$48.6B
$19.1M 0.04%
1,193,891
+46,999
+4% +$956K
INSP icon
165
Inspire Medical Systems
INSP
$1.75B
$18.9M 0.04%
313,610
+39,819
+15% +$2.95M
FTDR icon
166
Frontdoor
FTDR
$5.89B
$18.9M 0.04%
543,070
+428,509
+374% +$18.2M
RMBS icon
167
Rambus
RMBS
$10.7B
$18.5M 0.04%
1,666,504
+231,187
+16% +$3.2M
PB icon
168
Prosperity Bancshares
PB
$8.82B
$18.5M 0.04%
382,476
-7,361
-2% -$479K
YMAB
169
DELISTED
Y-mAbs Therapeutics
YMAB
$18.4M 0.04%
706,915
+161,859
+30% +$4.7M
CHDN icon
170
Churchill Downs
CHDN
$6.03B
$18.3M 0.04%
354,880
-48,468
-12% -$3.13M
XIFR
171
XPLR Infrastructure LP
XIFR
$1.08B
$18.1M 0.04%
419,918
+12,924
+3% +$685K
ZD icon
172
Ziff Davis
ZD
$1.99B
$18M 0.04%
276,171
+18,177
+7% +$1.42M
WEX icon
173
WEX
WEX
$6.36B
$17.9M 0.04%
170,969
-102,031
-37% -$19M
CHE icon
174
Chemed
CHE
$7.21B
$17.7M 0.04%
40,888
+2,573
+7% +$1.15M
VCYT icon
175
Veracyte
VCYT
$3.73B
$17.6M 0.04%
+724,273
New +$18.2M

Similar funds

Loomis, Sayles & Company's Q1 2020 Portfolio in Review

As of Q1 2020, Loomis, Sayles & Company held 822 positions worth $48.5B, down 17% from $58.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Loomis, Sayles & Company's Q1 2020 filing shows 91 new, 234 increased, 365 reduced and 101 closed positions. Its largest new stake was Salesforce: 6,849,609 shares worth $986M. The largest sale was Coca-Cola, an estimated $1.11B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Loomis, Sayles & Company's largest Q1 2020 buy was Salesforce: 6,849,609 shares worth $986M.
  • Loomis, Sayles & Company added most to Boeing in Q1 2020, an estimated $863M increase.
  • Loomis, Sayles & Company's biggest Q1 2020 reduction was Coca-Cola, cutting an estimated $1.11B.
  • Loomis, Sayles & Company fully exited Interxion Holding N.V. in Q1 2020, selling an estimated $50.7M.
  • Loomis, Sayles & Company's ten largest holdings make up 41% of its $48.5B portfolio in Q1 2020.
  • Loomis, Sayles & Company opened 91 new positions and closed 101 in Q1 2020.
  • Loomis, Sayles & Company's portfolio value fell 17% quarter-over-quarter to $48.5B.

Based on Loomis, Sayles & Company's 13F filing for Q1 2020, filed 15 May 2020.